Novus Capital will be the Lead M&A Partner of Russian Pharmaceutical Forum in 2017

25 Apr, 2017 13:00

We are pleased to inform you that Novus Capital for the second time will be the Lead M&A Partner of Russian Pharmaceutical Forum in 2017. The event will take place on 16-17 May, 2017 in St. Petersburg, the Forum is now in its 23rd year, and, with over 700 attendees annually, it has long been established as the leading international gathering for senior professionals working or interested in Russian or the CIS region (www.russianpharma.com).

On 16 May Novus Capital will host the 5th M&A and Business Development roundtable discussion. This year we are inviting M&A and Business Development practitioners from both multinational and local companies, as well from Private Equity funds. The following companies have already confirmed participation Egis, Acino, Alvogen and Baring Vostok Capital Partners. We will discuss current M&A trends in Russia, opportunities and challenges Russian market presents. This will be a good platform for the exchange of ideas and networking.

As sponsors of the Forum we have a 15% discount for participation, which we are happy to propose to you. If you are interested to attend, please contact us at admin@novuscapital.ru and we will provide you the promotion code.